Waterloo Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Waterloo Capital’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.71M	Buy	297,136 +32,774	+12%	+$646K	0.4%	63
2025 Q4	$5.01M	Buy	264,362 +2,764	+1%	+$51.2K	0.36%	64
2025 Q3	$4.88M	Buy	261,598 +6,668	+3%	+$125K	0.36%	65
2025 Q2	$4.7M	Buy	254,930 +12,894	+5%	+$229K	0.38%	57
2025 Q1	$4.23M	Buy	242,036 +21,319	+10%	+$359K	0.39%	62
2024 Q4	$3.82M	Buy	220,717 +357	+0.2%	+$6.52K	0.4%	63
2024 Q3	$4.1M	Sell	220,360 -25,982	-11%	-$438K	0.45%	54
2024 Q2	$3.79M	Buy	246,342 +16,474	+7%	+$235K	0.46%	56
2024 Q1	$3.4M	Buy	229,868 +67,254	+41%	+$931K	0.43%	56
2023 Q4	$2.32M	Buy	+162,614	New	+$2.31M	0.38%	68

Other funds holding SBRA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Principal Financial Group

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return